121 related articles for article (PubMed ID: 15903280)
1. A pharmacological surveillance study of the tolerability of policosanol in the elderly population.
Fernández S; Más R; Gamez R; Diaz A; Fernández J; Deibis Orta S; Illnait J; Castańo G; Mendoza S; Valdés F; Alvarez E
Am J Geriatr Pharmacother; 2004 Dec; 2(4):219-29. PubMed ID: 15903280
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
[TBL] [Abstract][Full Text] [Related]
3. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
[TBL] [Abstract][Full Text] [Related]
6. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
7. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
8. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.
Castaño G; Más R; Fernández JC; Fernández L; Illnait J; López E
Drugs R D; 2002; 3(3):159-72. PubMed ID: 12099160
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
[TBL] [Abstract][Full Text] [Related]
10. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.
Castaño G; Arruzazabala ML; Fernández L; Mas R; Carbajal D; Molina V; Illnait J; Mendoza S; Gámez R; Mesa M; Fernández J
Curr Ther Res Clin Exp; 2006 May; 67(3):174-92. PubMed ID: 24678094
[TBL] [Abstract][Full Text] [Related]
11. Effects of policosanol on postmenopausal women with type II hypercholesterolemia.
Castaño G; Más R; Fernández L; Fernández JC; Illnait J; López LE; Alvarez E
Gynecol Endocrinol; 2000 Jun; 14(3):187-95. PubMed ID: 10923280
[TBL] [Abstract][Full Text] [Related]
12. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
[TBL] [Abstract][Full Text] [Related]
13. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
[TBL] [Abstract][Full Text] [Related]
14. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
Castaño G; Más R; Fernández J; López E; Illnait J; Fernández L; Mesa M
Curr Ther Res Clin Exp; 2003 Sep; 64(8):522-37. PubMed ID: 24944402
[TBL] [Abstract][Full Text] [Related]
15. A long-term study of policosanol in the treatment of intermittent claudication.
Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
[TBL] [Abstract][Full Text] [Related]
16. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
Castaño G; Más R; Fernández JC; Illnait J; Fernández L; Alvarez E
J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M186-92. PubMed ID: 11253161
[TBL] [Abstract][Full Text] [Related]
17. Policosanol: a new treatment for cardiovascular disease?
Janikula M
Altern Med Rev; 2002 Jun; 7(3):203-17. PubMed ID: 12126462
[TBL] [Abstract][Full Text] [Related]
18. Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients.
Arruzazabala ML; Más R; Molina V; Carbajal D; Mendoza S; Fernández L; Valdés S
Int J Tissue React; 1998; 20(4):119-24. PubMed ID: 10093795
[TBL] [Abstract][Full Text] [Related]
19. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
Más R; Castaño G; Illnait J; Fernández L; Fernández J; Alemán C; Pontigas V; Lescay M
Clin Pharmacol Ther; 1999 Apr; 65(4):439-47. PubMed ID: 10223782
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.
Xu K; Liu X; Li Y; Wang Y; Zang H; Guo L; Wang Y; Zhao W; Wang X; Han Y
Cardiovasc Ther; 2016 Oct; 34(5):337-42. PubMed ID: 27328023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
